# Encompass Health Corporation – Consensus ‘strong_buy’ rating and 30.9% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-consensus-strong_buy-rating-and-30.9-upside-potential/4121131749
- Published: 2023-11-01T14:55:19+00:00
- Author: Charlotte Edwards

**Encompass Health Corporation** which can be found using ticker (EHC) have now 
9 market analysts covering the stock. The analyst consensus now points to a rating
of ‘strong_buy’. The range between the high target price and low target price is
between $85.00 and $77.00 suggesting an average Analsyt target price of $81.89. 
Given that the stocks previous close was at $62.56 this would indicate that there
is a potential upside of 30.9%. The day 50 moving average is $66.93 and the 200 
moving average now moves to $63.44. The company has a market capitalization of 6.18B.
The stock price for the company is currently $61.64 USD

 The potential market cap would be $8,087,212,112 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 17.36, revenue per share of $47.19
and a 7.9% return on assets.

Encompass Health Corporation is a provider of post-acute healthcare service. The
Company manages its operations through its inpatient rehabilitation segment. The
Company is the owner and operator of rehabilitation hospitals. It operates hospitals
in approximately 37 states and Puerto Rico, with concentrations in the eastern half
of the United States and Texas. The Company operates approximately 156 inpatient
rehabilitation hospitals. It provides specialized rehabilitative treatment on an
inpatient basis. The Company’s inpatient rehabilitation hospitals offer specialized
rehabilitative care across an array of diagnoses and deliver comprehensive patient
care services. It also provides rehabilitative care for patients recovering from
injury or illness, using advanced technology and treatments to maximize recovery.
Its hospitals provide a comprehensive interdisciplinary clinical approach to treatment
that leverages technologies and advanced therapies and leads to superior outcomes.

Share on: